Search hospitals > Ohio > Canton

Neuro-Behavioral Clinical Research, Inc

Claim this profile
Canton, Ohio 44718
Global Leader in Depression
Global Leader in Major Depressive Disorder
Conducts research for Schizophrenia
Conducts research for Alzheimer's Disease
Conducts research for Attention Deficit Hyperactivity Disorder (ADHD)
95 reported clinical trials
1 medical researcher
Photo of Neuro-Behavioral Clinical Research, Inc in CantonPhoto of Neuro-Behavioral Clinical Research, Inc in CantonPhoto of Neuro-Behavioral Clinical Research, Inc in Canton

Summary

Neuro-Behavioral Clinical Research, Inc is a medical facility located in Canton, Ohio. This center is recognized for care of Depression, Major Depressive Disorder, Schizophrenia, Alzheimer's Disease, Attention Deficit Hyperactivity Disorder (ADHD) and other specialties. Neuro-Behavioral Clinical Research, Inc is involved with conducting 95 clinical trials across 49 conditions. There are 1 research doctors associated with this hospital, such as Shishuka Malhotra, MD.

Area of expertise

1Depression
Global Leader
Neuro-Behavioral Clinical Research, Inc has run 27 trials for Depression. Some of their research focus areas include:
MGH-ATRQ
Selective Serotonin Reuptake Inhibitors (SSRI)
Serotonin-Norepinephrine Reuptake Inhibitors (SNRI)
2Major Depressive Disorder
Global Leader
Neuro-Behavioral Clinical Research, Inc has run 23 trials for Major Depressive Disorder. Some of their research focus areas include:
MGH-ATRQ
Selective Serotonin Reuptake Inhibitors (SSRI)
Serotonin-Norepinephrine Reuptake Inhibitors (SNRI)

Top PIs

Clinical Trials running at Neuro-Behavioral Clinical Research, Inc

Depression
Schizophrenia
Adolescent Health
Pediatric Migraine
Bipolar Depression
Obsessive-Compulsive Disorder
Major Depressive Disorder
Sickle Cell Anemia
Sickle Cell Disease
Alzheimer's Disease
Image of trial facility.

Investigational Drug

for Bipolar Depression

A clinical trial to study the efficacy and safety of an investigational drug in people with major depressive episodes associated with with Bipolar I disorder (bipolar I depression) Participants in the study will either receive the drug being studied or a placebo. The study will be conducted in approximately 90 sites in North America, Europe, Latin America and Japan. It will be have both male and female participants ages 18-65. Participation in the study will be approximately 10 weeks.
Recruiting1 award Phase 35 criteria
Image of trial facility.

BI 1569912

for Depression

This study is open to adults between 18 and 65 with a type of depression (major depressive disorder) for whom previous treatments for depression did not work. The purpose of the study is to find out whether a medicine called BI 1569912 helps people with depression. Participants continue their standard therapy throughout the study. Participants are put into 4 groups by chance. 3 of the 4 groups take different doses of BI 1569912. 1 group takes placebo. Placebo tablets looks like BI 1569912 but do not contain any medicine. Participants take the tablets once a day for 6 weeks. Participants are in the study for about 2 to 4 and a half months. During this time, they visit the study site at least 6 times. At the visits, doctors ask participants about their symptoms. The participants answer questions about their depression symptoms. The results are compared between the groups. The doctors also regularly check the general health of participants.
Recruiting0 awards Phase 2

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Neuro-Behavioral Clinical Research, Inc?
Neuro-Behavioral Clinical Research, Inc is a medical facility located in Canton, Ohio. This center is recognized for care of Depression, Major Depressive Disorder, Schizophrenia, Alzheimer's Disease, Attention Deficit Hyperactivity Disorder (ADHD) and other specialties. Neuro-Behavioral Clinical Research, Inc is involved with conducting 95 clinical trials across 49 conditions. There are 1 research doctors associated with this hospital, such as Shishuka Malhotra, MD.